The concept behind Dapi’s Discovery Pyramid took shape in 2017 during early research work at Precisemed, laying the foundation for what would become a bold new approach to pharmaceutical innovation. What began 

as a focused effort to address overlooked health conditions has since evolved into a globally-minded initiative. 

In recent years, this work has expanded to integrate artificial intelligence (AI) into the drug discovery process — enabling faster, smarter identification of treatment candidates for health conditions with few or no effective options. 

This progress led to the launch of AF Therapeutics and AFAM Pharma, operating under the official Trade marked brand name PharmaMedic™, a UK-based Podcast brand dedicated to explaining the science behind ethical, OTCs, synthetic and AI-powered medical innovations. 

Precisemed Limited specializes in the development of novel Over-the- counter (OTC) oral medicines, topical patches and gels 

AFAM Pharma specializes in the development of novel Synthetic medicines, medical devices as wearables and repurposed combination therapies 

AF Therapeutics specializes in the development of novel AI-driven medical devices as largely Brain Computer Interface devices(BCIs) ad AI-driven Synthetic drug molecules 

All our products are developed with one mission in mind: to improve lives and compliment conventional options. 

Through the PharmaMedic podcast, we also bring science to life, helping the public better understand the innovations shaping the future of medicine. 

While headquartered in the UK, PharmaMedic is built with global impact in mind. Our retail product launches are planned across the UK this year, with expansion into Europe, North America, and other regions soon to follow.